Journals / Gazi Medical Journal / 2018 / Cilt: 29 - Sayı: 4

Prognostic Value of Mean Platelet Volume in Glioblastoma Multiforme

Glioblastoma Multiforme’de Ortalama Platelet Hacminin Prognostik Değeri

Pages
336–339
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

MPV was an independent prognostic factor in GBM.Conclusions: MPV is a cheap, easily accessible and reproducible test that canbe used prognostically in GBM patients before treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Glioblastoma multiforme (GBM) is the most common primarymalignant brain tumor.
📊
Key Findings & Data:Kaplan-Meier methodand Cox regression were used to evaluate the prognostic impact of MPV.Results: Kaplan-Meier survival curves showed that patients belonging to thehigh-MPV group had a worse median OS (14 month versus 20 month,P=0.004).
💡
Conclusion & Impact:MPV was an independent prognostic factor in GBM.Conclusions: MPV is a cheap, easily accessible and reproducible test that canbe used prognostically in GBM patients before treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Glioblastoma multiforme (GBM) is the most common primarymalignant brain tumor. Despite optimal treatment (maximal surgicalresection, adjuvant radiotherapy and chemotherapy), the prognosis is verypoor. Beside known prognostic factors, there is no method at the time ofdiagnosis to predict recurrence. We aimed to identify mean platelet volume(MPV) as an indicator of prognosis in GBM.Methods: One hundred and seven patients who were diagnosed with GBMhistopathologically, admitted to the medical oncology clinic were included.MPV values were recorded for all patients at diagnosis. Kaplan-Meier methodand Cox regression were used to evaluate the prognostic impact of MPV.Results: Kaplan-Meier survival curves showed that patients belonging to thehigh-MPV group had a worse median OS (14 month versus 20 month,P=0.004). MPV was an independent prognostic factor in GBM.Conclusions: MPV is a cheap, easily accessible and reproducible test that canbe used prognostically in GBM patients before treatment.

Özet

Amaç: Glioblastoma multiforme (GBM) en sık görülen primer malign beyin tümörüdür. Optimal tedaviye rağmen (maksimal cerrahi rezeksiyon, adjuvan radyoterapi ve kemoterapi) prognoz oldukça kötüdür. Bilinen prognostik faktörlerin yanı sıra, tanı anında nüksü öngörmek için herhangi bir yöntem yoktur. Bu çalışmada GBM'de ortalama trombosit hacmininin (MPV) prognoz ile ilişkisini değerlendirmeyi amaçladık. Yöntem: Histopatolojik olarak GBM tanısı alan ve medikal onkoloji kliniğine başvuran 107 hasta çalışmaya dahil edildi. Hastaların tanı anındaki MPV değerleri kaydedildi. MPV'nin prognostik etkisini değerlendirmek için Kaplan- Meier yöntemi ve Cox regresyonu kullanıldı. Bulgular: Kaplan-Meier sağkalım eğrileri, yüksek MPV grubuna ait hastaların daha kısa sağkalıma sahip olduğunu gösterdi (14 ay vs 20 ay , P = 0.004).MPV, GBM’de bağımsız bir prognostik faktördür. Sonuç: GBM hastalarında, tedavi öncesi MPV değerleri prognostik olarak kullanılabilecek ucuz, kolay erişilebilir ve tekrarlanabilir bir testtir.

🔖

Cite This Article

UNER, A., TAHTACI, M., TAHTACI, G., GÜNEL, N. (2022). Prognostic Value of Mean Platelet Volume in Glioblastoma Multiforme. Gazi Medical Journal, Cilt: 29 - Sayı: 4, 336–339. https://ajindex.com/articles/519829

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Alifieris C, Trafalis DT. Glioblastoma multiforme: Pathogenesis and treatment. Pharmacol Ther. 2015, 152: 63-82
  2. Gittleman H, Lim D, Kattan MW,Chakravarti A, Gilbert MR, Lassman AB, Lo SS, Machtay M, Sloan AE, Sulman EP, et al. An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825. Neuro Oncol. 2017, 19:669-77
  3. Zhao H, Wang S, Song C, Zha Y, Li L. The prognostic value of MGMT promoter status by pyrosequencing assay for glioblastoma patients' survival: a meta- analysis. World J Surg Oncol. 2016, 14:261. Mezouar S, Frère C, Darbousset R, Mege D, Crescence L, Dignat-George F, Panicot-Dubois L, Dubois C. Role of platelets in cancer and cancer-associated thrombosis: Experimental and clinical evidences. Thromb Res. 2016, 139: 65- 76. Xie X, Zeng X, Cao S, Hu X, Shi Q, Li D, Zhou S, Gu P, Zhang Z. Elevated pretreatment platelet distribution width and platelet count predict poor prognosis in nasopharyngeal carcinoma. Oncotarget. 2017, 8:106089-106097
  4. Zhou Q, Huang F, He Z, Zuo MZ. Clinicopathological and prognostic significance of platelet count in patients with ovarian cancer. Climacteric. 2018, 21: 60-8
  5. Kimyon Cömert G, Türkmen O Kar İ, Sınacı S, Yılmaz Ergani S, Karalök A.et al. Independent predictors of survival in endometrium cancer: platelet-to- lymphocyte ratio and platelet/neutrophil/monocyte-to-lymphocyte ratio. J Turk Ger Gynecol Assoc. 2018, 19:78-86
  6. Kılınçalp S, Ekiz F, Başar O, Ayte MR, Coban S, Yılmaz B, Altınbaş A, Başar N, Aktaş B, Tuna Y. et al. Mean platelet volume could be possible biomarker in early diagnosis and monitoring of gastric cancer. Platelets. 2014, 25:592-4
  7. Wang X, Cui MM, Xu Y, Liu L, Niu Y, Liu T, Liu ZP, Wang RT, Yu KJ. Decreased mean platelet volume predicts poor prognosis in invasive bladder cancer. Oncotarget. 2017, 8:68115-22
  8. Gao L, Zhang H, Zhang B, Zhang L, Wang C. Prognostic value of combination of preoperative platelet count and mean platelet volume in patients with resectable non-small cell lung cancer. Oncotarget. 2017, 8:15632-41
  9. Sharma D, Brummel-Ziedins KE, Bouchard BA, Holmes CE. Platelets in tumor progression: a host factor that offers multiple potential targets in the treatment of cancer. J Cell Physiol. 2014, 229:1005-15.
  10. Li N, Yu Z, Zhang X, Liu T, Sun YX, Wang RT, Yu KJ. Elevated mean platelet volume predicts poor prognosis in colorectal cancer. Sci Rep. 2017, 7: 10261 Gu M, Zhai Z, Huang L, Zheng W, Zhou Y, Z